Company K Partners is a principal investment firm based in Gyeonggi-do, South Korea, established in 2006. The firm focuses on investments in various industries, including cultural content, electronic components, computer technology, machinery, broadcasting, arts, sports, and leisure. While primarily investing in South Korea, particularly in the regions of Seoul, Gyeongnam, and Gyeonggi, Company K Partners also seeks opportunities in the information technology and healthcare sectors.
Medipixel, Inc., founded in 2017 and based in Seoul, South Korea, specializes in developing artificial intelligence-based diagnostic software and semi-autonomous surgical tools for lung cancer and cardiac disease interventions. The company employs a team of experts in computer vision, deep learning, and reinforcement learning, collaborating with leading healthcare institutions to enhance diagnostic and surgical processes. Medipixel offers several innovative solutions, including an AI-based diagnosis tool that assists doctors in identifying lesions during coronary angiography, a guide and planning solution that visualizes hidden coronary artery segments to facilitate guidewire manipulation, and an automated navigation engine that optimizes robotic control for surgical procedures. By integrating advanced AI technologies, Medipixel aims to improve the quality of medical care and patient outcomes in the field of surgery.
Fadu
Venture Round in 2023
FADU Inc. is a fabless semiconductor company based in Seoul, South Korea, with an additional office in Mountain View, California. Founded in 2015, FADU specializes in the design and manufacture of memory and storage solutions, focusing on innovative Flash storage technology. The company has developed products such as the FADU Annapurna and FADU Bravo SSD controllers, aimed at addressing the increasing demands for data storage in enterprise datacenters. With a team comprising talented architects, ASIC experts, and seasoned SSD engineers, FADU aims to introduce next-generation storage products that stand out in a rapidly evolving industry. The company is dedicated to advancing Flash storage architecture and supply chain solutions to meet the diverse needs of modern data environments.
LUNASOFT
Venture Round in 2022
LUNASOFT INC. is a South Korean company established in 2016, specializing in the development of chatbots and an integrated management platform designed for customer support. The company offers a range of products, including Luna Plus, a courier exchange platform, Luna Plus Mobile, which provides real-time business consultation, and Luna Plus CTI, a customer counseling platform that merges phone and intelligent chat counseling. Additionally, LUNASOFT develops customer consultation chatbots for popular messaging platforms such as Naver and Kakao, catering specifically to e-commerce businesses.
Spark Biopharma
Series C in 2022
SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique drug molecule diversity technology, the image-based screening technology using the unique fluorescent skeleton probe, and the target protein identification technology in the initial drug development stage. We are currently exploring and developing new drug candidates using these three core technologies, and we will continue to accelerate the development of new drugs and increase the success rate through strategic cooperation research with domestic and overseas research institutes and pharmaceutical institutions. '
Organoid Sciences
Series B in 2022
Organoid Sciences is a drug development company based in Seongnam-si, South Korea, founded in 2018. The company specializes in organoid-based treatments and utilizes cannabinoid-based technology to create drugs aimed at addressing various incurable diseases. In addition to drug development, Organoid Sciences provides drug screening services and focuses on regenerative medicine, contributing to advancements in healthcare solutions.
afun interactive
Series B in 2021
Afun Interactive Inc. is a virtual reality company based in Seoul, South Korea, founded in 2016. The company specializes in three-dimensional rendering technologies and produces real-time content for various applications, including augmented reality and virtual reality. It focuses on creating and distributing digital content tailored to the unique needs of its clients, serving both the entertainment industry and other sectors that require advanced 3D animations and graphics. Through its expertise in real-time rendering technology, Afun Interactive aims to innovate and enhance the user experience in digital environments.
Bankware Global
Series B in 2021
Founded in 2010 and headquartered in Seoul, Korea, Bankware Global is a banking software developer that specializes in providing core banking solutions and financial software systems. The company serves a diverse clientele, including retail, corporate, private, treasury, fund administration, microfinance, and community banks, with over 100 financial institutions across seven countries in the Asia Pacific region. Notably, five digital banks in Korea, China, Japan, and Taiwan utilize Bankware Global's core banking software, highlighting the company's reputation as a leading provider in this sector. With offices in three countries, Bankware Global is recognized for its expertise in creating comprehensive financial institution products and transaction business software tailored for both domestic and international markets.
Return Zero
Series B in 2021
Return Zero, Inc. is a company that specializes in developing an artificial intelligence-based voice recognition application designed to convert phone dialogues into messenger chats. Founded in 2011 and based in Seoul, South Korea, the company offers services that transform audio phone messages into text, facilitating easier communication through messaging platforms.
TCUBEit
Venture Round in 2021
TCUBEit Inc. is a biotechnology company based in Sejong, South Korea, with an additional location in Cheongju. Founded in 2019, TCUBEit specializes in T cell-based immunotherapy, focusing on the collection and organization of T cells from patients. The company is dedicated to enhancing both the quantity and quality of T cells, which play a crucial role in identifying and eliminating cancers and infections in the human body. Moreover, TCUBEit is involved in the research, development, and commercialization of T-cell receptor-based cellular therapeutics, facilitating the discovery of innovative personalized therapies for cancer treatment.
Watcha
Venture Round in 2020
WATCHA, Inc. is a South Korean company that specializes in online interactive media services, primarily through its movie and TV series recommendation application. Launched in 2012, WATCHA quickly gained popularity in Korea as a leading movie review app, leveraging personalized recommendation technology to suggest films based on user ratings. The platform not only offers extensive movie and TV show reviews but also includes WATCHA PLAY, a subscription-based video-on-demand service launched in 2016. This service is accessible on various devices, including web browsers, mobile applications, and smart TVs. With a strong focus on accurate content recommendations, WATCHA claims that 75% of the content consumed on its platform is based on user-generated recommendations. The company, headquartered in Seoul, has also expanded its offerings to Japan, enhancing its position in the competitive media landscape.
HaplnScience
Seed Round in 2020
HaplnScience is a pharmaceutical company based in Seongnam-si, Gyeonggi-do, South Korea, founded in 2018. The company specializes in developing innovative anti-aging therapies aimed at reversing tissue and organ degeneration. Utilizing HAPLN1, a novel protein, HaplnScience's medications strengthen the extracellular matrix, which is crucial for maintaining healthy tissues. Their products are designed to prevent degeneration in various body tissues, addressing issues such as skin and hair aging, as well as effectively treating conditions like osteoarthritis. By focusing on these advancements, HaplnScience aims to enhance the health and quality of life for the elderly.
My Franchise
Series A in 2020
My Franchise is a company founded in 2019 in Seoul, South Korea, that addresses the information gap between franchise headquarters and potential founders. It operates an online platform that facilitates connections between these two parties, optimizing their partnership potential. The platform offers valuable insights for prospective founders, including data on the number of franchisees by year, average sales figures, and start-up costs associated with domestic franchise brands. This allows users to effectively compare and analyze important brand information across various industries, enabling informed decision-making for franchise investments.
Wave
Series B in 2020
Wave is an app that allows users to play games while group video chatting.
Nearthlab
Series B in 2020
Nearthlab, Inc. is a technology-focused start-up based in Seoul, South Korea, specializing in the development of autonomous drone systems primarily for the wind and renewable energy sectors. Founded by graduates of KAIST, the company leverages proprietary deep-learning algorithms to enhance safety inspections. Its flagship products include NearthWIND Pro, an autonomous drone designed for wind turbine inspections that can detect cracks and damages using AI, Zoomable, a cloud-based platform for managing and analyzing inspection data, and NearthWIND Mobile, a mobile solution for autonomous flight control. Nearthlab's AI technology allows for efficient autonomous flight in low-computing power and low-latency conditions, significantly reducing inspection times from hours to minutes. The company is supported by prominent venture capital firms in Korea, positioning it as a leader in drone technology for inspection purposes.
RIDI
Series E in 2020
RIDI Corporation is South Korea’s one of the largest digital content publication & distribution companies, mainly known for vitalizing the Korean e-book industry as well as empowering the web novel, webcomic, animation, articles, and news media. RIDI believes that rich imagination and deep insight serve as nutrients to make the human mind fertile and delivers them through its digital contents.
Organoid Sciences
Series A in 2020
Organoid Sciences is a drug development company based in Seongnam-si, South Korea, founded in 2018. The company specializes in organoid-based treatments and utilizes cannabinoid-based technology to create drugs aimed at addressing various incurable diseases. In addition to drug development, Organoid Sciences provides drug screening services and focuses on regenerative medicine, contributing to advancements in healthcare solutions.
Return Zero
Venture Round in 2020
Return Zero, Inc. is a company that specializes in developing an artificial intelligence-based voice recognition application designed to convert phone dialogues into messenger chats. Founded in 2011 and based in Seoul, South Korea, the company offers services that transform audio phone messages into text, facilitating easier communication through messaging platforms.
afun interactive
Venture Round in 2019
Afun Interactive Inc. is a virtual reality company based in Seoul, South Korea, founded in 2016. The company specializes in three-dimensional rendering technologies and produces real-time content for various applications, including augmented reality and virtual reality. It focuses on creating and distributing digital content tailored to the unique needs of its clients, serving both the entertainment industry and other sectors that require advanced 3D animations and graphics. Through its expertise in real-time rendering technology, Afun Interactive aims to innovate and enhance the user experience in digital environments.
Neofect
Post in 2019
Neofect is a South Korea-based company founded in 2010 by Hoyoung Ban, Scott Kim, and Young Choi, specializing in the development of rehabilitation training products and services for patients with neurological and musculoskeletal injuries. Its flagship product, the RAPAEL Smart Glove, launched in 2014, received FDA clearance and has been adopted by various hospitals and rehabilitation centers, including NewYork-Presbyterian and the Department of Veterans Affairs. In addition to the Smart Glove, Neofect offers several other innovative devices, such as the RAPAEL Smart Board, RAPAEL Smart Pegboard, RAPAEL Smart Kids, and RAPAEL Cognition, which utilize virtual reality and smart technology to enhance rehabilitation outcomes. Neofect has also participated in research studies demonstrating the effectiveness of its VR-based rehabilitation solutions compared to traditional therapy. The company operates in South Korea, the U.S., and Germany, distributing its products across these regions and throughout Europe.
Buffett Seoul
Series A in 2019
Buffett Seoul, founded in 2017 and headquartered in Seoul, South Korea, specializes in group physical training services aimed at delivering a unique fitness experience. The company offers a differentiated approach to fitness through an optimized group matching service that aligns participants based on their physique, exercise levels, and personal goals. This tailored methodology allows users to benefit from customized fitness programs that integrate both offline classes and online home training, enhancing the overall effectiveness of their fitness journey.
Anymedi
Venture Round in 2019
Anymedi Inc. is a South Korea-based company that specializes in the manufacturing of personalized medical devices. It provides a comprehensive platform that includes medical image upload, 3D modeling for clinical applications, and 3D printing services. The company focuses on developing patient-specific solutions for surgical procedures, addressing defects, disorders, and diseases by utilizing medical image data. Anymedi produces tailored 3D-printed simulators, surgical guides, and implants, integrating advanced technologies such as artificial intelligence and 3D printing to enhance surgical outcomes.
MediaFront
Venture Round in 2019
Mediafront is a media agency based in Seoul, Korea.
1drop
Venture Round in 2019
1drop Inc., founded in 2017 and based in Seongnam-si, South Korea, specializes in developing and manufacturing biosensor-based mobile healthcare devices. The company utilizes the optical components of smartphones to create in vitro diagnostic tools that enable disease prevention and healthcare management. Its platform allows users to monitor their health with just a single drop of blood, employing machine learning algorithms alongside embedded smartphone cameras and lateral flow sensors to detect various biomarkers, including anemia, gout, cholesterol levels, and blood glucose levels. By focusing on accessible diagnostics, 1drop aims to empower individuals to lead healthier lives through effective health management solutions.
Butfit Seoul
Venture Round in 2019
Butfit Seoul Co., Ltd. is a fitness company based in Seoul, South Korea, established in 2018. It offers group circuit training sessions and combines online and offline exercise experiences. The company provides a platform for workout training and enables users to earn rewards through their participation in fitness activities. By focusing on both in-person and digital formats, Butfit Seoul aims to enhance community engagement in fitness and promote a healthy lifestyle among its users.
Gelato Lab
Venture Round in 2019
Gelato Lab Inc. is a South Korean company established in 2017, specializing in the development of a mobile application focused on nail art. The application offers users a platform to explore a variety of nail art designs, showcasing different colors, styles, and filters. This functionality allows customers to easily search for and select preferred designs and nail salons. By combining technology with beauty, Gelato Lab aims to enhance the nail art experience for users.
Lumir
Venture Round in 2018
Lumir Inc. is a company based in Seoul, South Korea, that specializes in designing, developing, and selling thermoelectric LED lamps powered by cooking oil. Founded in 2018, Lumir aims to address the global lighting challenge by providing innovative solutions. The company offers a variety of products, including table lamps, bulb lamps, and off-grid lamps, which are available for purchase online. Through its commitment to sustainability and social impact, Lumir seeks to create accessible and environmentally friendly lighting options for communities in need.
Cupix
Series A in 2018
Cupix, Inc. is a South Korean company founded in 2015, with subsidiaries in the U.S. and Australia, and offices in Singapore, the UK, and Lebanon. It specializes in cloud-based software that creates three-dimensional digital twins of physical spaces using 360-degree photos and affordable cameras. The platform employs advanced technologies such as computational geometry, computer vision, and machine learning to generate realistic 3D representations of buildings, construction sites, and large facilities. This innovative solution allows users to measure dimensions, annotate information, and simulate virtual objects, facilitating the design, construction, and management of properties. Cupix aims to enhance accessibility to physical spaces, enabling builders and property owners to virtually explore environments anytime and anywhere.
Tomocube
Venture Round in 2018
Tomocube Inc. specializes in the design and manufacture of 3D optical microscopes, particularly the HT-1 and HT-2 models, which offer holotomographic imaging and 3D fluorescence capabilities. Founded in 2015 and headquartered in Daejeon, South Korea, the company aims to enhance biological and medical research through innovative optical solutions. Unlike traditional optical microscopes that provide only 2D views, Tomocube's products enable researchers to obtain real-time, dynamic 3D images of living cells without the need for extensive sample preparation. This technology is particularly beneficial for studying various biological samples, including red blood cells, sperm cells, CAR-T cells, and more. By utilizing deep learning-based image recognition, Tomocube's microscopes allow for a better understanding of cellular dynamics, ultimately aiding in the diagnosis and treatment of human diseases.
Spark Biopharma
Venture Round in 2018
SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique drug molecule diversity technology, the image-based screening technology using the unique fluorescent skeleton probe, and the target protein identification technology in the initial drug development stage. We are currently exploring and developing new drug candidates using these three core technologies, and we will continue to accelerate the development of new drugs and increase the success rate through strategic cooperation research with domestic and overseas research institutes and pharmaceutical institutions. '
Wave
Venture Round in 2018
Wave is an app that allows users to play games while group video chatting.
PinotBio
Series A in 2017
PinotBio, Inc., based in Suwon, South Korea, is a biotechnology company focused on researching and developing small molecule drugs in the fields of ophthalmology and oncology. The company is engaged in pre-clinical trials for NTX-101, a treatment designed for glaucoma, as well as other technologies targeting anticancer therapies through epigenetics. PinotBio aims to create innovative treatments that assist in managing refractory and relapsed cancers, enhancing the ability of healthcare providers to treat patients with life-threatening conditions. Founded in 2017, the company is dedicated to addressing unmet medical needs in these critical areas.
Neofect
Series C in 2017
Neofect is a South Korea-based company founded in 2010 by Hoyoung Ban, Scott Kim, and Young Choi, specializing in the development of rehabilitation training products and services for patients with neurological and musculoskeletal injuries. Its flagship product, the RAPAEL Smart Glove, launched in 2014, received FDA clearance and has been adopted by various hospitals and rehabilitation centers, including NewYork-Presbyterian and the Department of Veterans Affairs. In addition to the Smart Glove, Neofect offers several other innovative devices, such as the RAPAEL Smart Board, RAPAEL Smart Pegboard, RAPAEL Smart Kids, and RAPAEL Cognition, which utilize virtual reality and smart technology to enhance rehabilitation outcomes. Neofect has also participated in research studies demonstrating the effectiveness of its VR-based rehabilitation solutions compared to traditional therapy. The company operates in South Korea, the U.S., and Germany, distributing its products across these regions and throughout Europe.
MediaFront
Seed Round in 2017
Mediafront is a media agency based in Seoul, Korea.
Anymedi
Venture Round in 2017
Anymedi Inc. is a South Korea-based company that specializes in the manufacturing of personalized medical devices. It provides a comprehensive platform that includes medical image upload, 3D modeling for clinical applications, and 3D printing services. The company focuses on developing patient-specific solutions for surgical procedures, addressing defects, disorders, and diseases by utilizing medical image data. Anymedi produces tailored 3D-printed simulators, surgical guides, and implants, integrating advanced technologies such as artificial intelligence and 3D printing to enhance surgical outcomes.
Catenoid
Series C in 2017
Catenoid, Inc. is a South Korean company that specializes in developing an online video platform and providing cloud computing services. As the first company to launch an online video platform in Korea, Catenoid delivers a seamless video service to over 700 domestic and international clients. The company offers Video Technology as a Service (VTaaS), which combines software, hardware, and network components into a unified platform tailored for various industries, including online education, video commerce, broadcasting, and corporate media. This integration enables businesses to access optimized video services, enhancing their operational capabilities and overall user experience.
RIDI
Series C in 2017
RIDI Corporation is South Korea’s one of the largest digital content publication & distribution companies, mainly known for vitalizing the Korean e-book industry as well as empowering the web novel, webcomic, animation, articles, and news media. RIDI believes that rich imagination and deep insight serve as nutrients to make the human mind fertile and delivers them through its digital contents.
PinotBio
Seed Round in 2017
PinotBio, Inc., based in Suwon, South Korea, is a biotechnology company focused on researching and developing small molecule drugs in the fields of ophthalmology and oncology. The company is engaged in pre-clinical trials for NTX-101, a treatment designed for glaucoma, as well as other technologies targeting anticancer therapies through epigenetics. PinotBio aims to create innovative treatments that assist in managing refractory and relapsed cancers, enhancing the ability of healthcare providers to treat patients with life-threatening conditions. Founded in 2017, the company is dedicated to addressing unmet medical needs in these critical areas.
Tomocube
Venture Round in 2017
Tomocube Inc. specializes in the design and manufacture of 3D optical microscopes, particularly the HT-1 and HT-2 models, which offer holotomographic imaging and 3D fluorescence capabilities. Founded in 2015 and headquartered in Daejeon, South Korea, the company aims to enhance biological and medical research through innovative optical solutions. Unlike traditional optical microscopes that provide only 2D views, Tomocube's products enable researchers to obtain real-time, dynamic 3D images of living cells without the need for extensive sample preparation. This technology is particularly beneficial for studying various biological samples, including red blood cells, sperm cells, CAR-T cells, and more. By utilizing deep learning-based image recognition, Tomocube's microscopes allow for a better understanding of cellular dynamics, ultimately aiding in the diagnosis and treatment of human diseases.
RIDI
Series D in 2016
RIDI Corporation is South Korea’s one of the largest digital content publication & distribution companies, mainly known for vitalizing the Korean e-book industry as well as empowering the web novel, webcomic, animation, articles, and news media. RIDI believes that rich imagination and deep insight serve as nutrients to make the human mind fertile and delivers them through its digital contents.
Lumir
Venture Round in 2016
Lumir Inc. is a company based in Seoul, South Korea, that specializes in designing, developing, and selling thermoelectric LED lamps powered by cooking oil. Founded in 2018, Lumir aims to address the global lighting challenge by providing innovative solutions. The company offers a variety of products, including table lamps, bulb lamps, and off-grid lamps, which are available for purchase online. Through its commitment to sustainability and social impact, Lumir seeks to create accessible and environmentally friendly lighting options for communities in need.
ST Unitas
Series B in 2015
ST Unitas Co. Ltd. is an EduTech company based in Seoul, South Korea, that specializes in creating educational content and programs aimed at facilitating university entrance exam preparation, job searching, and language acquisition. Founded in 2010 and formerly known as ST & Company, the company operates branches across various regions in South Korea, including Busan, Incheon, and Gyeonggi-do. ST Unitas offers a diverse range of learning applications, such as "Connect," which provides courses on academics, diet, reading, fashion, and life skills. The company emphasizes collaboration with non-profit organizations, social enterprises, governments, and global entities to enhance educational outcomes and foster a positive societal impact. ST Unitas is driven by a vision of creating innovative content that contributes to personal and community development, prioritizing meaningful goals over mere profitability.
ZigBang
Venture Round in 2015
ZigBang Co., Ltd. is a South Korean company founded in 2010, specializing in a property listing platform that connects real estate agents with renters. The company offers a user-friendly marketplace for apartment hunting through its mobile and web applications, allowing users to search for rental properties based on criteria such as the number of rooms, occupants, and price. ZigBang has reported approximately 6 million users, although this figure includes both active and inactive accounts. The platform aims to simplify the rental process and help users make informed choices while potentially saving money on housing.
GPCR Therapeutics
Venture Round in 2015
GPCR Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Seoul, South Korea, specializing in the development of pharmaceutical products that target G Protein-Coupled Receptors (GPCRs). Founded in 2013, the company focuses on addressing unmet medical needs by leveraging proprietary GPCR data to create innovative therapeutics, particularly for cancer and other diseases lacking effective treatments. By employing novel approaches to target GPCRs, GPCR Therapeutics aims to provide patients with new options for managing their conditions.
RIDI
Series B in 2014
RIDI Corporation is South Korea’s one of the largest digital content publication & distribution companies, mainly known for vitalizing the Korean e-book industry as well as empowering the web novel, webcomic, animation, articles, and news media. RIDI believes that rich imagination and deep insight serve as nutrients to make the human mind fertile and delivers them through its digital contents.
Ybrain
Series A in 2014
Ybrain Inc. is a South Korean company founded in 2013, specializing in the development of wearable devices that utilize neuroscience technology to address brain disorders and enhance mental well-being. The company focuses on creating solutions for patients with Alzheimer’s and mild cognitive impairment, as well as those suffering from neuropsychiatric illnesses such as Major Depressive Disorder (MDD). Ybrain's products include a wireless EEG system that facilitates the collection of brain signal data and a non-invasive brain stimulation device that employs weak electrical currents to stimulate brain activity. Currently, the company is conducting clinical trials in Korea and is also working on a big data platform that leverages brain signals collected through its proprietary qEEG software, aiming to provide more targeted and personalized treatment options.
Polygon Games
Series A in 2014
Polygon Games is a Korean game developer that serves the needs of the global markets. The company has developed ASTA: The War of Tears and Winds, an upcoming massively multiplayer online role-playing game. It was launched in 2008 and is based in Seoul, Seoul-t’ukpyolsi.
ChannelBreeze
Series B in 2014
ChannelBreeze (채널브리즈) is a Korean company that provides social commerce services through an online platform including social network services. ChannelBreeze also provides search engine-based web services for real estate.
Iamcompany
Series A in 2014
Iamcompany is a student startup affiliated with the KAIST Midam committee, focusing on enhancing educational opportunities through internet-based technologies. With an investment of 2 billion won from various investors, the company aims to identify and develop students' potential. Its primary services include the mobile app 'iamschool,' which delivers news and updates from educational institutions to caregivers, allowing them to follow and engage with schools similarly to social media platforms. Additionally, the web service 'iamclass' provides direct information about students and institutions to caregivers while also serving as an advertising channel for educational entities. Through these platforms, Iamcompany seeks to foster a more conducive learning environment for students in South Korea.
NHN Edu
Seed Round in 2014
NHN Edu Corp. is an online educational services provider based in Seongnam, South Korea. The company specializes in designing and developing web and mobile platforms for education, including IMS School, IMT, Union, and Pink Diary. NHN Edu's class management platform supports teachers in organizing classes, tracking student behavior, and facilitating communication with parents. This functionality aims to enhance the learning environment and promote student growth.
ZigBang
Series B in 2014
ZigBang Co., Ltd. is a South Korean company founded in 2010, specializing in a property listing platform that connects real estate agents with renters. The company offers a user-friendly marketplace for apartment hunting through its mobile and web applications, allowing users to search for rental properties based on criteria such as the number of rooms, occupants, and price. ZigBang has reported approximately 6 million users, although this figure includes both active and inactive accounts. The platform aims to simplify the rental process and help users make informed choices while potentially saving money on housing.
Perples
Venture Round in 2014
Perples, Inc. is a South Korean technology company established in 2012, specializing in the development of Internet of Things (IoT) solutions, particularly through its RECO beacon. This device utilizes Bluetooth technology to facilitate proximity sensing, enabling store owners to engage with customers based on their location within the store. By communicating with customers' smart devices, RECO provides alerts for coupons, promotions, and other relevant information to enhance the shopping experience. Additionally, Perples develops software focused on context targeting and event performance analysis, offering data-driven marketing solutions to enterprise clients. Through these innovations, the company aims to improve customer interactions and optimize marketing strategies.
Neofect
Venture Round in 2012
Neofect is a South Korea-based company founded in 2010 by Hoyoung Ban, Scott Kim, and Young Choi, specializing in the development of rehabilitation training products and services for patients with neurological and musculoskeletal injuries. Its flagship product, the RAPAEL Smart Glove, launched in 2014, received FDA clearance and has been adopted by various hospitals and rehabilitation centers, including NewYork-Presbyterian and the Department of Veterans Affairs. In addition to the Smart Glove, Neofect offers several other innovative devices, such as the RAPAEL Smart Board, RAPAEL Smart Pegboard, RAPAEL Smart Kids, and RAPAEL Cognition, which utilize virtual reality and smart technology to enhance rehabilitation outcomes. Neofect has also participated in research studies demonstrating the effectiveness of its VR-based rehabilitation solutions compared to traditional therapy. The company operates in South Korea, the U.S., and Germany, distributing its products across these regions and throughout Europe.
BioLeaders
Venture Round in 2012
BioLeaders Corporation is a healthcare company based in Yongin, South Korea, founded in 1999. The company focuses on developing innovative medicines, particularly in the field of oncology, with its flagship product being P53, an anti-cancer drug. BioLeaders is advancing several pipeline products, including BLS-H01, currently in phase 3 clinical trials for cervical cancer, and BLS-M07, which has completed phase 2b trials for the same condition. Additionally, the company is working on BLS-M22 for the treatment of Duchenne muscular dystrophy and BLC-H03, a vaccine adjuvant. Beyond pharmaceuticals, BioLeaders also offers health functional foods, raw materials, and functional cosmetic ingredients, positioning itself as a comprehensive provider in the healthcare sector.
LifeLiver
Venture Round in 2011
LifeLiver rights to cell therapies HepaStem and H2Stem to treat liver diseases in South Korea. The companies will jointly develop the products to treat non-alcoholic steatohepatitis (NASH) and acute-on-chronic liver failure (ACLF), and...
L&K Biomed
Venture Round in 2010
L&K Biomed Ltd. is a medical device manufacturer based in Seoul, South Korea, specializing in the research, development, and sale of orthopedic spinal implants. Established in 2008, the company offers a diverse range of products, including cervical spine solutions like anterior cervical plate systems and posterior cervical fixation systems, as well as thoraco-lumbar spine products such as spinal fixation systems and various types of cages for different surgical approaches. In addition to its spinal product line, L&K Biomed is engaged in the development of cardiovascular devices and cell simulation kits, serving both domestic and international markets.
Abion
Venture Round in 2009
Abion Inc. is a biotechnology company based in Seoul, South Korea, specializing in the development of chemical and biological drugs and vaccines. Founded in 2007, Abion focuses on advancing therapies for cancer and autoimmune diseases. Its portfolio includes several anticancer drug candidates, such as ABN401 for lung and stomach cancer, ABN501 as a biomarker for breast and ovarian cancers, and ABN201, a fusion protein designed to target cancer cells. Additionally, the company is developing ABN101, an interferon-beta based biological drug aimed at treating autoimmune diseases affecting the central nervous system. Abion also works on ABN701, a vaccine targeting staphylococcal enterotoxin B, and ABN601, a drug intended to protect the immune system from acute radiation syndrome.
BNC Korea
Venture Round in 2009
BNC Korea Co., Ltd. is a South Korean company based in Daegu that specializes in the research, development, production, and sale of biomaterials. Founded in 2007, it focuses on creating products for the beauty and medical markets, including a range of hyaluronic acid fillers and skin boosters designed to temporarily reduce facial wrinkles. Notable products include Cutegel, Cutegel Lidocaine, and various skin treatment solutions such as face mask gels and brightening peeling gels. Additionally, BNC Korea manufactures medical products like Hibarry, which aids in wound care, and GENTA Q, a collagen sponge for wound protection. The company exports its innovative offerings to 45 countries, demonstrating its commitment to enhancing both aesthetic and therapeutic applications in the field of biomaterials.
Enzychem Lifesciences
Venture Round in 2008
Enzychem Lifesciences is a Global New Drug Development Company that was founded on the most advanced life sciences and technologies of medicinal chemistry in July 1999. With its Global New Drug R&D center located in KAIST in Daejeon and its two GMP manufacturing plants in Seoul, it has since been developing and producing APIs and functional health foods, and developing global new drugs as the leader of the field.
Carver Korea
Venture Round in 2008
Carver Korea Co., Ltd., based in Seoul, South Korea, is a prominent cosmetics manufacturer known for its diverse range of products in skincare, make-up, and fashion. The company owns several brands, including A.H.C (Aesthetic Hydration Cosmetics), Shara Shara, and Vivito, as well as women's apparel under the brand Lenouvelle. Carver Korea's product offerings include eye creams, essences, toners, and other skincare essentials. These products are distributed through various channels such as home shopping television networks, retail stores, duty-free shops, beauty salons, skincare clinics, and e-commerce platforms, catering primarily to consumers in Korea. Since November 2017, Carver Korea has operated as a subsidiary of Unilever PLC.
Aprogen Healthcare & Games
Venture Round in 2008
Aprogen Healthcare & Games Inc. is a South Korean company based in Seongnam, founded in 1998. The company specializes in the development of medicines utilizing biomedical technology and offers innovative wireless communication solutions, including a remote lighting monitoring and control system for streetlights and security lamps. In addition to its healthcare and technology services, Aprogen is also involved in the mobile gaming industry, publishing popular games such as Dragon Raja M, Legendary Heroes, Heroes & Titans, and Flame Shadow. The company's diverse portfolio reflects its commitment to integrating healthcare, technology, and entertainment.
MEKICS
Venture Round in 2008
MEKICS Co., Ltd is a medical device company based in Paju, South Korea, specializing in the design, manufacture, and sale of equipment for intensive care units. The company provides a range of respiratory treatment devices, including artificial respirators suitable for critical patients, patient monitors, positive airway pressure devices for home use, medical ventilators, pulse oximeters, and central monitoring systems. Additionally, MEKICS operates a Home Rental business that leases artificial respirators to patients with chronic respiratory conditions. The company's Home Healthcare division develops and markets the M3 device, a continuous positive airway pressure treatment instrument aimed at addressing sleep apnea and snoring, along with a monitoring service accessible via online and mobile applications. Founded in 1998, MEKICS is committed to improving patient care through innovative medical technology.
Automobile & PCB
Venture Round in 2008
Automobile & PCB Inc. is a South Korean manufacturer specializing in printed circuit boards (PCBs). Established in 1977 and headquartered in Bucheon, the company produces a diverse range of PCB products, including thin PCBs for cellular phones and portable electronics, build-up PCBs for communication devices, B.V.H PCBs for electronic communication, and multi-layer PCBs for networking equipment. Its offerings also extend to double-sided PCBs suitable for general electronics and home appliances. In addition to its manufacturing capabilities, Automobile & PCB Inc. has established overseas branches in India and China, enhancing its global presence. The company has achieved various quality certifications, underscoring its commitment to high standards in production.
Humasis
Venture Round in 2008
Humasis Co. Ltd. is a South Korean company that specializes in the development, manufacturing, and marketing of in-vitro diagnostic products. Its offerings include tests for cardiac markers, fertility hormones, infectious diseases, tumor markers, and cotinine, catering to both home and laboratory use. The company produces pregnancy and ovulation self-test products and provides Hubi-Quan Pro, a device that delivers rapid quantitative results for various tests. Founded in 2000 and based in Anyang, Humasis is also involved in point-of-care testing and the study of rapid test kits, serving markets both domestically and internationally.
Optrontec
Venture Round in 2008
Optrontec Inc. is a South Korean company operating in the optoelectronics industry, specializing in the development and manufacturing of optical components. Founded in 1989 and headquartered in Changwon, the company offers a range of products, including image sensing optical filters such as reflective blue and absorptive IR cut-off filters, band pass filters, and absorptive film filters. These products are utilized across various applications, including visible light imaging, iris and fingerprint recognition, infrared technology, biometrics, 3D sensing, and facial recognition. Additionally, Optrontec manufactures optical lenses, including focus lenses and trifocal lenses for sectors such as automotive, life sciences, imaging, and defense. The company also provides modules and systems, featuring IR filter assemblies, LWIR sets, and components for mobile camera apertures.
AngioLab
Venture Round in 2008
AngioLab, Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the development of medicines utilizing angiogenesis inhibitors for the treatment of diseases related to angiogenesis. The company is advancing several products through clinical trials, including AL101-NASH for non-alcoholic steatohepatitis and AL101-OME for otitis media with effusion, as well as AL102-PDT for periodontitis and AL101-PSO for psoriasis. Additionally, it is conducting Phase 2 trials for AL101-AMD to address age-related macular degeneration and AL101-AOB for abnormal obesity. AngioLab is also developing AL201-AB, currently in the preclinical stage, targeting cancer and ocular diseases. Furthermore, the company offers ob-X, a product aimed at visceral fat reduction. Founded in 1999, AngioLab reflects a commitment to innovation and stability in the biotechnology sector.
Micro Digital
Venture Round in 2008
Micro Digital is a South Korea-based biotechnology company that specializes in providing systems for the biomedical and environmental industries. Its product offerings include a Fully Automatic Immuno Analyzer, Integrated Sample Banking Solution, Microplate Luminometer, Nano Spectrophotometer, and a Biomass Desiccation and Pulverization System. The company focuses on developing innovative solutions that cater to the needs of research and development in the biomedical sector.
HUNESION
Venture Round in 2005
Hunesion Co., Ltd, founded in 2006 and based in Seoul, South Korea, develops and supplies a range of IT security solutions. The company's offerings include i-oneNet, a secure data transmission solution; i-oneNet DD, which provides one-way physical network connectivity; i-Spector for network traffic collection and analysis; TresDM, an intelligent malware detection solution; NGS for system access control and account management; CamPASS, a CCTV password management solution; MoBiCa, an enterprise mobile device management solution; and ViSiCa, a visit and safety management solution. Hunesion focuses on addressing various aspects of IT security to enhance data protection and system integrity.
Payletter
Venture Round in 2003
Payletter Inc. is a company that specializes in online billing and payment services, serving clients across North America, Europe, and Asia. Founded in 2001 and headquartered in Seoul, South Korea, Payletter offers solutions like BillOneQ, which tracks digital content usage, including fixed amounts, time of use, and recurring charges, catering specifically to gaming, PC rooms, and digital products. Additionally, the company provides payoneQ, an integrated payment agent service designed to facilitate secure transactions. Payletter's platform is equipped with advanced security features, such as SSL support and AES encryption, ensuring efficient and secure payment solutions for its users, particularly in the gaming and digital content sectors.
Mobiis
Venture Round in 2002
Mobiis Co., Ltd. is a South Korean company based in Seongnam that specializes in designing and building equipment and systems for monitoring and controlling particle accelerator beams and related technologies. Founded in 2000, Mobiis offers a range of products, including control systems and equipment such as low-level radio frequency amplifiers, solid-state amplifiers, undulator controllers, and step motor controllers. The company also develops control systems for nuclear fusion reactors, incorporating services like control data access, communication frameworks, central interlock systems, and coil power supply systems. Additionally, Mobiis is involved in computer programming, system integration, and engineering services, providing intelligent control solutions across various sectors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.